scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
TL;DR: Evidence of a rising burden of both premenopausal and postmenopausal breast cancer worldwide is provided, although early diagnosis and access to treatment remain crucial in low-income and middle-income countries.

313 citations

Journal ArticleDOI
Rafael Lozano1, Nancy Fullman, Degu Abate2, Solomon M Abay  +1313 moreInstitutions (252)
TL;DR: A global attainment analysis of the feasibility of attaining SDG targets on the basis of past trends and a estimates of health-related SDG index values in countries assessed at the subnational level varied substantially, particularly in China and India, although scores in Japan and the UK were more homogeneous.

312 citations

Journal ArticleDOI
TL;DR: Support is provided for the MFSI-SF as a valuable tool for the multidimensional assessment of cancer-related fatigue as evidenced by commonly used goodness of fit indices.

311 citations

Journal ArticleDOI
TL;DR: While prostate cancer remains largely a disease diagnosed in older men (over age 65), screening has increased risk of diagnosis among men in their 40s and 50s, and outcome studies suggest that many men who are diagnosed with “localized early stage disease” actually have “apparently localizedEarly stage disease,” which is really low volume metastatic disease.
Abstract: Prostate cancer is a significant public health issue in the United States. It is the most commonly diagnosed non-skin cancer and the second leading cause of cancer death. The American Cancer Society estimates that in 2011, 240,890 men were diagnosed with prostate cancer and 33,720 men died of it. A review of the peer-reviewed literature was conducted: American Cancer Society, National Cancer Institute Surveillance, Epidemiology and End Results. Program data were assessed to describe trends in incidence, mortality, and survival rates and look at other predictors of risk of prostate cancer diagnosis and death. Since 1985, there have been significant changing trends in prostate cancer incidence, mortality, and survival rates, as well as changes in the age distribution of the population diagnosed and even in the distribution of pathologies at diagnosis. Major risk factors for diagnosis include age, family history, race, and screening behavior. While prostate cancer remains largely a disease diagnosed in older men (over age 65), screening has increased risk of diagnosis among men in their 40s and 50s. The incidence rates and 5-year survival rates are heavily influenced by the introduction of serum prostate-specific antigen (PSA) and widespread screening. The effects of PSA usage and screening on mortality rates are less certain. Outcome studies among men treated with radical prostatectomy show that greater than 30% relapse rates are common. This suggests that many men who are diagnosed with “localized early stage disease” actually have “apparently localized early stage disease,” which is really low volume metastatic disease.

308 citations

Journal ArticleDOI
TL;DR: The results emphasize the importance of WC as a risk factor for mortality in older adults, regardless of BMI.
Abstract: Methods: We examined the association between WC and mortality among 48500 men and 56343 women, 50 years or older, in the Cancer Prevention Study II Nutrition Cohort. A total of 9315 men and 5332 women died between 1997 and the end of follow-up in 2006. Results: After adjustment for BMI and other risk factors, very high levels of WC were associated with an approximately 2-fold higher risk of mortality in men and women (among men, relative risk [RR]=2.02; 95% confidence interval [CI], 1.71-2.39 for WC 120 cm compared with 90 cm; among women, RR=2.36; 95% CI, 1.98-2.82forWC110cmcomparedwith75cm).The WC was positively associated with mortality within all categories of BMI. In men, a 10-cm increase in WC was associated with RRs of 1.16 (95% CI, 1.09-1.23), 1.18 (95%CI,1.12-1.24),and1.21(95%CI,1.13-1.30)within normal(18.5to25),overweight(25to30),andobese (30) BMI categories, respectively. In women, corresponding RRs were 1.25 (95% CI, 1.18-1.32), 1.15 (95% CI, 1.08-1.22), and 1.13 (95% CI, 1.06-1.20). Conclusion:These results emphasize the importance of WC as a risk factor for mortality in older adults, regardless of BMI.

305 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194